Skip to main content

Table 2 Patients’ baseline drug resistance pattern

From: High rate of successful treatment outcomes among childhood rifampicin/multidrug-resistant tuberculosis in Pakistan: a multicentre retrospective observational analysis

Variables Frequency (%)
Number and pattern drug resistance
 One 83 (39.0)
  R 83 (39.0)
 Two 32 (15.0)
  RH 31
  R + Eto 1
 Three 37 (17.4)
  RH + FQ 14
  RHZ 12
  RHS 5
  RHE 4
  RH + SLI 2
 Four 21 (9.9)
  RHEZ 9
  RHZ + FQ 5
  RHZS 3
  RHES 2
  REZS 1
  RHZ + SLI 1
 Five 25 (11.7)
  RHEZS 14
  RHEZ + FQ 8
  RHES + FQ 2
  RHZS + Eto 1
 Six 12 (5.6)
  RHEZS + FQ 12
 Seven 3 (1.4)
  RHEZS + FQ + Eto 3
 Resistance to R 213 (100)
 Resistance to H 129 (60.6)
 Resistance to E 54 (25.4)
 Resistance to Z 67 (31.5)
 Resistance to S 48 (21.9)
 Resistance to all five FLDs 29 (13.6)
 Resistance to any SLDs 50 (23.0)
 Resistance to FQs 45 (21.1)
 Resistance to any SLI 3 (1.4)
 Resistance to Eto 5 (2.3)
  1. E ethambutol, Eto ethionamide, FLDs first line anti-TB drugs, FQs fluoroquinolones, H isoniazid, R rifampicin, S streptomycin, SLDs second-line anti-TB drugs, SLI second line injectable, Z pyrazinamide